top of page
< Back

Development of RNA-targeted therapies for bleeding disorders, especially von Willebrand disease.

Prof H.C.J. Eikenboom

Development of RNA-targeted therapies for bleeding disorders, especially von Willebrand disease.

2015

bottom of page